
Mark Trudeau
Mark C. Trudeau is a global executive and board member with decades of experience building, scaling, and transforming... | Palm Coast, Florida, United States
*50 free lookup(s) per month.
No credit card required.
Mark Trudeau’s Emails ma****@te****.com
Mark Trudeau’s Phone Numbers No phone number available.
Social Media
Mark Trudeau’s Location Palm Coast, Florida, United States
Mark Trudeau’s Expertise Mark C. Trudeau is a global executive and board member with decades of experience building, scaling, and transforming multinational organizations. A seasoned leader and strategist, he has piloted public companies through exponential growth and significant adversity—developing businesses with the resiliency and grit to overcome headwinds at the industry, market, and organizational levels. Career highlights: • 30+ years in healthcare—global operations, R&D, supply chain, finance, commercial—plus governance and advisory experience for non-healthcare organizations. • Unique experience taking a company public through spinoff, managing corporate bankruptcy, leading major restructuring efforts, overhauling portfolios via R&D and acquisitions, modernizing supply chain and business operations, preparing international markets for new product launches, etc. • History of influencing public policy and navigating changeable regulatory environments in the US and around the world. • Demonstrated success developing strong cultures and diverse, best-in-class leadership teams that consistently outperform—regardless of the challenges that come their way. Public companies: Mallinckrodt plc, Covidien plc, Bayer AG, Bristol-Myers Squibb Geographies: North America, Europe, Asia Board of directors roles (select list): TE Connectivity, Mallinckrodt plc, PhRMA, Biotechnology Innovation Organization (BIO), BJC Investigator Program, National Association of Manufacturers (NAM), Rx&D, and others, including nonprofits
Mark Trudeau’s Current Industry Te Connectivity
Mark
Trudeau’s Prior Industry
Bristol Myers Squibb
|
Bayer
|
Bayer Pharmaceuticals
|
Covidien
|
Mallinckrodt Pharmaceuticals
|
Te Connectivity
Not the Mark Trudeau you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience

Te Connectivity
Board Member | Compensation & Audit Committees
Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Mallinckrodt Pharmaceuticals
President & CEO | Board Member | Portfolio Committee
Fri Feb 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Covidien
President, Mallinckrodt plc | SVP, Covidien plc
Sun Jan 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Bayer Pharmaceuticals
CEO & Board Member, Bayer Healthcare, LLC
Fri Jan 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Jan 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Bayer
Interim President, Global Specialty Medicine (Bayer Healthcare, LLC)
Fri Jan 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Jan 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Bayer
President, Bayer Healthcare Pharmaceuticals, USA
Thu Jan 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Jan 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
SVP / General Manager, Immunoscience, US Pharmaceuticals
Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
President, Asia Pacific
Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
President & General Manager, Canada
Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Jan 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
Managing Director, United Kingdom
Tue Jan 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) — Wed Jan 01 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
Commercial Director, United Kingdom
Mon Jan 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jan 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
Vice President, Immunology, Global Marketing
Sat Jan 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Bristol Myers Squibb
Vice President, US Infectious Disease Marketing
Thu Jan 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Jan 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time)